NCNMGF
AUTL

Nano-Cap New Millennium Growth Fund’s Autolus Therapeutics AUTL Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Hold
150,000
– – 0.18% 104
2026
Q1 		$207K Buy
150,000
+37,500
+33% +$57K 0.19% 111
2025
Q4 		$224K Buy
+112,500
New +$173K 0.19% 115

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's AUTL Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund held its Autolus Therapeutics (AUTL) position steady in Q2 2026 at 150,000 shares worth $240K. The position accounts for 0.18% of the portfolio, ranked #104.

Nano-Cap New Millennium Growth Fund first reported a position in AUTL in Q4 2025 and has held it in 3 quarters since. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 150,000 shares of Autolus Therapeutics worth $240K as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund left its Autolus Therapeutics share count unchanged in Q2 2026.
  • Autolus Therapeutics made up 0.18% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #104 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Autolus Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.